Chloe Cole
Transgender Detransitioner

Chloe Cole underwent  medical “transition” of her biological sex as a female from ages 13-16. After informing her parents that she identified as a transgender boy at 12, she was diagnosed in July 2017 with dysphoria by a “gender specialist” the following month. Chloe began puberty blockers in February of 2018, and one month later received her first testosterone shot. At the age of 15, Chloe had top surgery: the removal of her breasts. Despite consultations, Chloe was not aware of long-term health effects to which she did not knowingly consent. In addition to never being able to breastfeed her future children, she developed urinary tract issues including blood clots; the effects of her reproductive system due to the testosterone is completely unknown. Saying, “I have irreversible changes, and I may face complications for the rest of my life,” Cloe firmly attests, “I was failed by modern medicine.”